Composition
- Active ingredients
- SUNVOZERTINIB 150MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SUNVOZERTINIB 200MG · TabletNDA219839-002 · Prescription
- SUNVOZERTINIB 150MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA219839.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zegfrovy
- Active substance
- sunvozertinib
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Dizal Jiangsu
- Status
- Prescription
- FDA approval
- 2 Jul 2025
- Application
- NDA219839-001
- RxCUI
- 2719232